CLEC9A and neoplasm: DCs were further subdivided into cDC1 (cross-presenting dendritic cells; cluster 5 in Paratumor and cluster 11 in Tumor; CLEC9A+ and XCR1+), cDC2 (cluster 1 in Paratumor and cluster 1 in Tumor; CD1C+) and plasmacytoid DC (pDC; cluster 4 in Paratumor and cluster 13 in Tumor; LILRA4+ and IL3RA+) (Figure 3C–3E).